---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-044151"
form_type: "8-K"
ticker: "KYMR"
cik: "0001815442"
company_name: "Kymera Therapeutics, Inc."
filed_at: "2025-03-03T23:59:59+00:00"
generated_at: "2026-05-25T20:12:00.088614+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Kymera grants PSUs to key employees with three clinical milestone vesting targets

## Summary
- PSUs vest in three installments: 40% for first milestone, 40% for second, 20% for third.
- No PSUs vest before first anniversary of grant date; total payout ranges 0-100% of target.
- Grants approved March 3, 2025 under 2020 Stock Plan for named executive officers and management.
- Target number of PSUs not disclosed; full award terms to be filed in Q1 2025 10-Q.

## SEC filing metadata
- accession: 0001193125-25-044151
- form_type: 8-K
- ticker: KYMR
- cik: 0001815442
- company_name: Kymera Therapeutics, Inc.
- filed_at: 2025-03-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815442/000119312525044151/0001193125-25-044151-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815442/000119312525044151/d940925d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-044151
- JSON: https://secwatch.observer/filing/0001193125-25-044151.json
- Plain text: https://secwatch.observer/filing/0001193125-25-044151.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.